New iPad tool could spot brain toxicity before symptoms show in CAR-T patients
NCT ID NCT07403812
First seen Feb 12, 2026 · Last updated May 12, 2026 · Updated 12 times
Summary
This study will test whether an iPad app called DCog Short can detect early signs of neurotoxicity (brain-related side effects) in 40 people receiving CAR-T cell therapy for blood cancers. Participants will use the app to self-report their thinking and memory, and results will be compared to standard doctor assessments. If successful, this tool could help catch problems earlier, allowing for quicker treatment and better outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.